178 related articles for article (PubMed ID: 29664936)
1. Olfactory dysfunction as a prognostic marker for disability progression in Multiple Sclerosis: An olfactory event related potential study.
Ciurleo R; Bonanno L; De Salvo S; Romeo L; Rifici C; Sessa E; D'Aleo G; Russo M; Bramanti P; Marino S; Caminiti F
PLoS One; 2018; 13(4):e0196006. PubMed ID: 29664936
[TBL] [Abstract][Full Text] [Related]
2. Olfactory dysfunction in multiple sclerosis.
Atalar AÇ; Erdal Y; Tekin B; Yıldız M; Akdoğan Ö; Emre U
Mult Scler Relat Disord; 2018 Apr; 21():92-96. PubMed ID: 29529530
[TBL] [Abstract][Full Text] [Related]
3. Smelling multiple sclerosis: Different qualities of olfactory function reflect either inflammatory activity or neurodegeneration.
Bsteh G; Berek K; Hegen H; Teuchner B; Auer M; Wurth S; Di Pauli F; Deisenhammer F; Berger T
Mult Scler; 2020 Jan; 26(1):57-68. PubMed ID: 30465490
[TBL] [Abstract][Full Text] [Related]
4. The association between olfactory bulb volume, cognitive dysfunction, physical disability and depression in multiple sclerosis.
Yaldizli Ö; Penner IK; Yonekawa T; Naegelin Y; Kuhle J; Pardini M; Chard DT; Stippich C; Kira JI; Bendfeldt K; Amann M; Radue EW; Kappos L; Sprenger T
Eur J Neurol; 2016 Mar; 23(3):510-9. PubMed ID: 26699999
[TBL] [Abstract][Full Text] [Related]
5. Change of olfactory function as a marker of inflammatory activity and disability progression in MS.
Bsteh G; Hegen H; Ladstätter F; Berek K; Amprosi M; Wurth S; Auer M; Di Pauli F; Deisenhammer F; Reindl M; Berger T; Lutterotti A
Mult Scler; 2019 Feb; 25(2):267-274. PubMed ID: 29185867
[TBL] [Abstract][Full Text] [Related]
6. Detection of olfactory dysfunction using olfactory event related potentials in young patients with multiple sclerosis.
Caminiti F; De Salvo S; De Cola MC; Russo M; Bramanti P; Marino S; Ciurleo R
PLoS One; 2014; 9(7):e103151. PubMed ID: 25047369
[TBL] [Abstract][Full Text] [Related]
7. Combined visual and motor evoked potentials predict multiple sclerosis disability after 20 years.
Schlaeger R; Schindler C; Grize L; Dellas S; Radue EW; Kappos L; Fuhr P
Mult Scler; 2014 Sep; 20(10):1348-54. PubMed ID: 24574192
[TBL] [Abstract][Full Text] [Related]
8. Olfactory dysfunction in multiple sclerosis: evidence of a decrease in different aspects of olfactory function.
Rolet A; Magnin E; Millot JL; Berger E; Vidal C; Sileman G; Rumbach L
Eur Neurol; 2013; 69(3):166-70. PubMed ID: 23257936
[TBL] [Abstract][Full Text] [Related]
9. Olfactory alterations in patients with multiple sclerosis.
Jordy SS; Starzewski A; Macedo FA; Manica GR; Tilbery CP; Carabetta EG
Arq Neuropsiquiatr; 2016 Sep; 74(9):697-700. PubMed ID: 27706416
[TBL] [Abstract][Full Text] [Related]
10. MRI study: objective olfactory function and CNS pathologies in patients with multiple sclerosis.
Holinski F; Schmidt F; Dahlslett SB; Harms L; Bohner G; Olze H
Eur Neurol; 2014; 72(3-4):157-62. PubMed ID: 25228293
[TBL] [Abstract][Full Text] [Related]
11. Prediction of long-term disability in multiple sclerosis.
Schlaeger R; D'Souza M; Schindler C; Grize L; Dellas S; Radue EW; Kappos L; Fuhr P
Mult Scler; 2012 Jan; 18(1):31-8. PubMed ID: 21868486
[TBL] [Abstract][Full Text] [Related]
12. Olfactory dysfunction in patients with multiple sclerosis.
Li LM; Yang LN; Zhang LJ; Fu Y; Li T; Qi Y; Wang J; Zhang DQ; Zhang N; Liu J; Yang L
J Neurol Sci; 2016 Jun; 365():34-9. PubMed ID: 27206870
[TBL] [Abstract][Full Text] [Related]
13. The utility of multimodal evoked potentials in multiple sclerosis prognostication.
Ramanathan S; Lenton K; Burke T; Gomes L; Storchenegger K; Yiannikas C; Vucic S
J Clin Neurosci; 2013 Nov; 20(11):1576-81. PubMed ID: 23827173
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal Testing of Olfactory and Gustatory Function in Patients with Multiple Sclerosis.
Uecker FC; Olze H; Kunte H; Gerz C; Göktas Ö; Harms L; Schmidt FA
PLoS One; 2017; 12(1):e0170492. PubMed ID: 28107525
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of no evidence of disease activity in a 7-year longitudinal multiple sclerosis cohort.
Rotstein DL; Healy BC; Malik MT; Chitnis T; Weiner HL
JAMA Neurol; 2015 Feb; 72(2):152-8. PubMed ID: 25531931
[TBL] [Abstract][Full Text] [Related]
16. Olfactory threshold is impaired in early, active multiple sclerosis.
Lutterotti A; Vedovello M; Reindl M; Ehling R; DiPauli F; Kuenz B; Gneiss C; Deisenhammer F; Berger T
Mult Scler; 2011 Aug; 17(8):964-9. PubMed ID: 21372115
[TBL] [Abstract][Full Text] [Related]
17. Employment and absenteeism in working-age persons with multiple sclerosis.
Salter A; Thomas N; Tyry T; Cutter G; Marrie RA
J Med Econ; 2017 May; 20(5):493-502. PubMed ID: 28035846
[TBL] [Abstract][Full Text] [Related]
18. Retinal and Optic Nerve Degeneration in Patients with Multiple Sclerosis Followed up for 5 Years.
Garcia-Martin E; Ara JR; Martin J; Almarcegui C; Dolz I; Vilades E; Gil-Arribas L; Fernandez FJ; Polo V; Larrosa JM; Pablo LE; Satue M
Ophthalmology; 2017 May; 124(5):688-696. PubMed ID: 28187977
[TBL] [Abstract][Full Text] [Related]
19. Spinal cord atrophy in multiple sclerosis and relationship with disability across clinical phenotypes.
Bernitsas E; Bao F; Seraji-Bozorgzad N; Chorostecki J; Santiago C; Tselis A; Caon C; Zak I; Millis S; Khan O
Mult Scler Relat Disord; 2015 Jan; 4(1):47-51. PubMed ID: 25787052
[TBL] [Abstract][Full Text] [Related]
20. Monitoring multiple sclerosis by multimodal evoked potentials: Numerically versus ordinally scaled scoring systems.
Schlaeger R; Hardmeier M; D'Souza M; Grize L; Schindler C; Kappos L; Fuhr P
Clin Neurophysiol; 2016 Mar; 127(3):1864-71. PubMed ID: 26754876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
